MedTech company TidalSense has closed a £7.5 million fundraising round.  The Cambridge-based company has created a handheld medical device, N-Tidal, that detects changes in lung function sensitively and enables quicker, more accurate and automated diagnosis of chronic obstructive pulmonary disease (COPD), with asthma to follow. Formerly known as Cambridge Respiratory Innovations, it is targeting the … Continue reading £7.5m for respiratory disease diagnosis startup TidalSense